EMERGENT BIOSOLUTIONS INC. Operating Leases, Future Minimum Payments Due, Next Twelve Months
EMERGENT BIOSOLUTIONS INC. (EBS) had Operating Leases, Future Minimum Payments Due, Next Twelve Months of $3.40 thousand as of 2018-12-31, per its 10-K filed 2019-02-22.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent · last filed 2019-02-22
- 2018-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $3.40K.
- 2017-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $1.63M.
- 2015-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $2.58M.
- 2014-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $2.56M.
| Period end | Operating Leases, Future Minimum Payments Due, Next Twelve Months |
|---|---|
| 2018-12-31 | $3.40K 10-K · filed 2019-02-22 |
| 2017-12-31 | $1.63M 10-K · filed 2018-02-23 |
| 2015-12-31 | $2.58M 10-K · filed 2016-02-29 |
| 2014-12-31 | $2.56M 10-K · filed 2015-03-09 |
| 2013-12-31 | $3.15M 10-K · filed 2014-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |